Gadolinium-free MRI contrast agent

SPAGO has recently achieved good results in in vivo and in vitro studies with gadolinium-free nanoparticles having sensationally high relaxivity. In addition to the high contrast achieved between tumor and surrounding tissue in vivo, there is no risk for NSF when using SPAGO Pix.